8217848falsethat of provision of medical consultancy2023-04-012024-03-31http://www.companieshouse.gov.uk/2023-03-31http://www.companieshouse.gov.uk/pt:ShareCapital2023-03-31http://www.companieshouse.gov.uk/cd:Director12023-04-012024-03-31http://www.companieshouse.gov.uk/pt:ShareCapital2024-03-31http://www.companieshouse.gov.uk/pt:ToolsEquipment2023-03-31http://www.companieshouse.gov.uk/cd:OrdinaryShareClass12023-04-012024-03-31http://www.companieshouse.gov.uk/pt:ToolsEquipment2024-03-31http://www.companieshouse.gov.uk/cd:RegisteredOffice2023-04-012024-03-31http://www.companieshouse.gov.uk/cd:AuditExemptWithAccountantsReport2023-04-012024-03-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2024-03-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2023-03-31http://www.companieshouse.gov.uk/2023-04-012024-03-31http://www.companieshouse.gov.uk/2023-03-31http://www.companieshouse.gov.uk/cd:FRS1022023-04-012024-03-31http://www.companieshouse.gov.uk/2024-03-31http://www.companieshouse.gov.uk/cd:FullAccounts2023-04-012024-03-31http://www.companieshouse.gov.uk/cd:PrivateLimitedCompanyLtd2023-04-012024-03-31iso4217:GBPxbrli:sharesxbrli:pure
Registered number: 8217848

A.L. MEDICAL LIMITED

ACCOUNTS
FOR THE YEAR ENDED 31/03/2024

Prepared By:
JAN G GROMADZKI
CHARTERED ACCOUNTANT
13 WOLVERHAMPTON ROAD
CODSALL
WOLVERHAMPTON
WEST MIDLANDS
WV8 1PT

A.L. MEDICAL LIMITED

ACCOUNTS
FOR THE YEAR ENDED 31/03/2024
DIRECTORS
Dr Ashraf S Labib
REGISTERED OFFICE
13 WOLVERHAMPTON ROAD
CODSALL
WOLVERHAMPTON
WEST MIDLANDS
WV8 1PT
COMPANY DETAILS
Private company limited by shares registered in EW - England and Wales, registered number 8217848
BANKERS
NATIONAL WESTMINSTER BANK Plc & BARCLAYS BANK UK PLC
ACCOUNTANTS
JAN G GROMADZKI
CHARTERED ACCOUNTANT
13 WOLVERHAMPTON ROAD
CODSALL
WOLVERHAMPTON
WEST MIDLANDS
WV8 1PT

A.L. MEDICAL LIMITED

ACCOUNTS
FOR THEYEARENDED31/03/2024
CONTENTS
Page
Directors' Report-
Accountants' Report-
Statement Of Comprehensive Income-
Balance Sheet3
Notes To The Accounts4
The following do not form part of the statutory financial statements:
Trading And Profit And Loss Account-
Profit And Loss Account Summaries-

A.L. MEDICAL LIMITED

BALANCE SHEET AT 31/03/2024
20242023
Notes££
FIXED ASSETS
Tangible assets213,11915,345
CURRENT ASSETS
Debtors3116,130116,130
116,130116,130
CREDITORS: Amounts falling due within one year4120,516119,791
NET CURRENT LIABILITIES(4,386)(3,661)
TOTAL ASSETS LESS CURRENT LIABILITIES8,73311,684
CAPITAL AND RESERVES
Called up share capital7100100
Profit and loss account8,63311,584
SHAREHOLDERS' FUNDS8,73311,684
For the year ending 31/03/2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have decided not to deliver to the registrar a copy of the company's profit and loss account.
Approved by the board on 24/11/2024 and signed on their behalf by
.............................
Dr Ashraf S Labib
Director

A.L. MEDICAL LIMITED

NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 31/03/2024
1. ACCOUNTING POLICIES
1a. Basis Of Accounting
The accounts have been prepared under the historical cost convention.
The accounts have been prepared in accordance with FRS102 - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006 .
1b. Depreciation
Depreciation is provided at rates calculated to write off the cost of fixed assets, less their estimated residual value, over their expected useful lives.
At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is an indication that any items have suffered impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss, if any.
Equipmentstraight line10%
1c. Basis Of Accounting FRS 1021 a
The accounts have been prepared under the historical cost convention and are stated in United Kingdom Pounds Sterling.
The accounts have been prepared in accordance with FRS102 section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
2. TANGIBLE FIXED ASSETS
EquipmentTotal
££
Cost
At 01/04/202322,26522,265
Disposals(1,400)(1,400)
At 31/03/202420,86520,865
Depreciation
At 01/04/20236,9206,920
Disposals(1,400)(1,400)
For the year2,2262,226
At 31/03/20247,7467,746
Net Book Amounts
At 31/03/202413,11913,119
At 31/03/202315,34515,345

A.L. MEDICAL LIMITED

3. DEBTORS 20242023
££
Amounts falling due within one year
Trade debtors111,954111,954
Prepayments4,1764,176
116,130116,130
4. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
20242023
££
UK corporation tax-4,678
VAT17,39817,398
PAYE control8651,867
Directors current account49,15243,114
Bank loans and overdrafts32,65033,008
Trade creditors2,3522,352
Accruals18,09917,374
120,516119,791
5. SECURED CREDITORS
20242023
££
Amount of bank loans and overdrafts which are secured32,65033,008
6. EMPLOYEES
20242023
No.No.
Average number of employees11
Key management personnel is restricted to that of the director.

A.L. MEDICAL LIMITED

7. SHARE CAPITAL 20242023
££
Allotted, issued and fully paid:
100 Ordinary shares of £1 each100100
100100
8. CONTROLLING PARTY
The company is wholly owned by the director Dr A S Labib.
9. RELATED PARTY TRANSACTIONS
The director Dr A S Labib received a dividend of £ nil in the year ended 31 March 2024 (2023 - £ nil).
10. NATURE OF OPERATIONS AND PRINCIPAL ACTIVITY
The company is principally involved in the provision of medical consultancy. All of which is carried out within the United Kingdom.
11. GENERAL INFORMATION
A.L. Medical Limited is a private company limited by shares and incorporated in England. Its registered office is 13 Wolverhampton Road, Codsall, Wolverhampton, West Midlands, WV8 1PT.
The financial statements are presented in United Kingdom Pounds Sterling, which is the functional currency of the company.